ABCG2 and neoplasm: The overexpression of several ABC transporters, including MDR1 and ABCG2, contributes to the multidrug resistance (MDR) phenotype, resulting in an efflux of drugs from tumor cells and decreased intracellular drug concentrations and toxicity.